Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Adenosylhomocysteinase pseudogene 8 (AHCYP8) is a pseudogene located at human chromosome 1q44[6]. Pseudogenes are segments of DNA similar to known genes but contain mutations that prevent them from producing functional proteins[2][4][6]. AHCYP8 is related to the functional gene encoding adenosylhomocysteinase (AHCY), an enzyme crucial for methylation metabolism, but AHCYP8 itself does not encode a functional enzyme or receptor[6][2][1]. While some pseudogenes have regulatory roles, there is no current evidence that AHCYP8 has any biological function, involvement in disease, or relevance as a drug target. Its classification as a pseudogene indicates it should not be considered a classical therapeutic target. If you were seeking information about the active enzyme, the relevant entity is "Adenosylhomocysteinase" (abbreviated as AHCY), an enzyme involved in methylation cycle reactions, not AHCYP8[1][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Adenosylhomocysteinase pseudogene 8 (AHCYP8).